| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 29, 2026 | ±3.1% | -4.6% | under-priced |
| October 31, 2025 | ±2.6% | -3.0% | under-priced |
| July 31, 2025 | ±1.9% | -1.3% | over-priced |
| May 2, 2025 | ±2.6% | +0.7% | over-priced |
| August 2, 2024 | ±4.1% | -4.2% | under-priced |
| May 3, 2024 | ±2.1% | -6.6% | under-priced |
| November 3, 2023 | ±2.8% | -0.3% | over-priced |
| August 4, 2023 | ±1.9% | -0.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.49 | $1.8B | $194M |
| Q4 FY2025 | $0.67 | $2.1B | $268M |
| Q3 FY2025 | $0.61 | $2.0B | $246M |
| Q2 FY2025 | $-0.29 | $1.9B | $-114M |
Ingersoll Rand Inc. Common Stock (IR) reports in 113 days, with the next report estimated for October 4, 2026. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 2.6% on average — the market has been roughly fair on IR's earnings risk. Fundamentals into the print: EPS up 6.5% year-over-year, revenue up 7.6%. QuantLogix's live 5-factor engine currently reads IR as a buy at 50/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →